✦ LIBER ✦

Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase

✍ Scribed by Luo, Y; Lai, X-Y; Tan, Y-M; Shi, J-M; Zhao, Y-M; Han, X-Y; Zheng, G-F; Zhu, X-L; Sun, J; Zheng, Y-L

Book ID: 109886778
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 116 KB
Volume: 23
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2008.401

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imatinib mesylate versus allogeneic BMT

Imatinib mesylate versus allogeneic BMT for patients with chronic myeloid leukemia in first chronic phase

✍ Bittencourt, H; Funke, V; Fogliatto, L; Magalhães, S; Setubal, D; Paz, A; Macedo 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 165 KB

Compliance with taking imatinib mesylate

Compliance with taking imatinib mesylate in patients with chronic myeloid leukemia in the chronic phase

✍ Toru Kiguchi; Tetsuzo Tauchi; Yoshikazu Ito; Keisuke Miyazawa; Yukihiko Kimura; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 485 KB

Use of a reduced-intensity conditioning

Use of a reduced-intensity conditioning regimen for allogeneic transplantation in patients with chronic myeloid leukemia

✍ Das, M; Saikia, T K; Advani, S H; Parikh, P M; Tawde, S 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

Clinical outcomes and direct hospital co

Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia

✍ Krejci, M; Mayer, J; Doubek, M; Brychtova, Y; Pospisil, Z; Racil, Z; Dvorakova, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 167 KB

Philadelphia-negative acute myeloid leuk

Philadelphia-negative acute myeloid leukemia with new chromosomal abnormalities developing after first-line imatinib treatment for chronic phase chronic myeloid leukemia

✍ Carmen Fava; Jorge Cortes 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

## Induction of integrin b 1 expression in bone marrow cells after chemotherapy correlates with the overexpression of lung resistance protein and poor outcome in patients with multiple myeloma To the Editor: Acquired drug resistance continues to be one of the major obstacles hindering the successf

Allogeneic hematopoietic stem cell trans

Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisis

✍ Ying Wang; Depei Wu; Aining Sun; Zhengming Jin; Huiying Qiu; Miao Miao; Xiaowen 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 160 KB